Using Molecular Biology to Develop Drugs for Renal Cell Carcinoma

Expert Opinion on Drug Discovery - United Kingdom
doi 10.1517/17460441.3.3.311
Full Text
Abstract

Available in full text

Categories
Drug Discovery
Date
Authors
Publisher

Informa Healthcare

Related search

Molecular Genetics of Clear-Cell Renal Cell Carcinoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Molecular Genetic Diagnostics of Clear Cell Renal Cell Carcinoma

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2016English

Update on the Biology and Management of Renal Cell Carcinoma

Journal of Investigative Medicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

Molecular Subtyping of Metastatic Renal Cell Carcinoma: Implications for Targeted Therapy

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2014English

Preoperative Embolization Using Absolute Ethanol for Renal Cell Carcinoma

Japanese Journal of Urology
Urology
1993English

Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs

Clinical Genitourinary Cancer
OncologyUrology
2016English

Molecular Biology and Gastric Carcinoma.

Gut
Gastroenterology
1993English

Renal Cell Carcinoma

World Journal of Urology
Urology
2016English

Molecular Recognition and in Vitro Targeted Inhibition of Renal Cell Carcinoma Using a DNA Aptamer

Molecular Therapy - Nucleic Acids
Drug DiscoveryMolecular Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy